study in patients with recurrent ir metastatic head & neck squamous cell carcinoma
Published 5 years ago • 369 plays • Length 9:31Download video MP4
Download video MP3
Similar videos
-
28:48
the changing treatment landscape in recurrent/metastatic squamous cell carcinoma of head & neck
-
1:13
keynote-b84: pepinemab pembrolizumab for metastatic/recurrent head & neck squamous cell carcinoma
-
6:46
first-line pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma
-
7:13
nivolumab confers better os in patients with metastatic squamous cell carcinoma of the head and neck
-
7:38
increased progression free survival for patients with metastatic head and neck cancer using afatinib
-
3:56
phase ii trial of pembrolizumab & cabozantinib in patients with recurrent metastatic hnscc
-
38:21
navigating the challenges of treatment provision in recurrent/metastatic hnscc
-
35:08
wellness unleashed with doc stone s1:e7: natural approaches to squamous cell carcinoma
-
5:05
pembrolizumab vs. standard treatment in patients with recurrent or metastatic head and neck cancer
-
4:42
pembrolizumab for recurrent head and neck squamous cell carcinomas (hnscc)
-
2:37
pembrolizumab is effective in recurrent, metastatic squamous cell carcinomas of the head and neck
-
2:36
ca209-9ky: imrt nivolumab for recurrent head and neck squamous cell cancer
-
1:58
dr. rischin on keynote-048 results in head and neck squamous cell carcinoma
-
3:35
recurrent or metastatic head and neck cancer - asco recaps head and neck cancer patient education
-
1:15
dr. ferris on significance of checkmate-141 trial for head and neck cancer
-
0:55
dr. cohen on immunotherapy in head and neck squamous cell carcinoma
-
3:50
managing head and neck cancer (squamous cell carcinoma)
-
3:05
checkmate 648: novel treatment for patients with advanced esophageal squamous cell carcinoma
-
3:14
factors predicting the outcome of immunotherapy to patients with head and neck cancer